Patrick Hanlon, MSc Public Health

Mr. Patrick Hanlon is a health economist at Swiss TPH who possesses over three decades of management experience in development and cooperation. Holder of a Master of Science/Public Health from the London School of Hygiene and Tropical Medicine in UK and a Bachelor in Commerce/Finance from Canada, he offers extensive experience gained through numerous long-term assignments: 2 years financial management in the Gambia; financial advisor for 3 years in Kenya; 5 years as country representative for the German Leprosy and TB Relief Association (GLRA) in Tanzania as well as 5 years as project department head of the GLRA in Wuerzburg, Germany. He has worked on several short-term assignments in Kenya, Tanzania, Ghana, Egypt, Namibia, Sudan, Sierra Leone, Nigeria, Ethiopia, Uganda, Cameroon, Romania, and Kosovo. From 2004 until joining Swiss TPH in 2009, Mr. Patrick Hanlon was an independent consultant and trainer for international and local NGOs in organizational and accountability optimization. He is certified in the Capacity Works model of the GIZ and trained in the use of the UN/WHO OneHealth national health plan costing tool. He co-led a cost analysis study of compact prefilled auto-disable delivery systems for vaccinations. Mr. Hanlon led the development and implementation of a cost-benefit tool for analysis of employee wellbeing programs for GIZ Ghana, Tanzania, Kenya and Namibia, with current application in Ivory Coast, Nigeria and Vietnam for OLAM International. He was part of the team, which conducted the Rapid Assessment of World Bank COVID-19 Multi-Phase programmatic approach, funded by Vital Strategies. Mr. Patrick Hanlon is providing his expertise since 2011 to the public financial management and health financing components of the Health Promotion and System Strengthening Project in Tanzania and 2015 to 2018 to the Health Facility Autonomy Project in Kyrgyzstan, both being financed by the SDC. He developed methods for and contributed to the economic analysis of SDC projects in Tanzania, Tajikistan, Moldova, and Ukraine as well as for the 3ie TRL study in Nigeria. He conducted an economic analysis for an ICRC clinical decision support system (ALMANACH) for diagnosing illnesses for under 5 years old and a business case projection tool for making the switch to better cheaper TB treatments for TB Alliance. He conducted a funding sustainability assessment of the German Institute for Medical Mission DIFAEM and is currently conducting cost/sustainability analysis for the Novartis Foundation CARDIO4Cities in Dakar and Sao Paulo. He teaches regularly in the field of economic evaluation in the health sector as well as financial management in various Masters and other programs. Native English, he is fluent in German.